Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Ravelli

Showing results (281-290 of 342) with videos related to

Pageof 35
Sort By:
Rheumatology (Oxford, England)|July 26, 2024
Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR projectFrancesco Baldo, Remco G A Erkens, Mao Mizuta, et al.
Rheumatology (Oxford, England)|August 30, 2023
Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severityAndrea Taddio, Sara Della Paolera, Luisa Abbagnato, et al.
Lancet (London, England)|February 7, 2017
Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trialAngelo Ravelli, Sergio Davì, Giulia Bracciolini, et al.
JAMA|April 8, 2010
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trialDirk Foell, Nico Wulffraat, Lucy R Wedderburn, et al.
Rheumatology (Oxford, England)|August 3, 2021
Canakinumab in systemic juvenile idiopathic arthritis: real-world data from a retrospective Italian cohortArianna De Matteis, Claudia Bracaglia, Denise Pires Marafon, et al.
Arthritis Care & Research|December 25, 2024
Do the Provisional Paediatric Rheumatology International Trials Organisation Enthesitis/Spondylitis-Related Juvenile Idiopathic Arthritis Criteria Capture Youth With Axial Spondyloarthritis?Pamela F Weiss, Timothy G Brandon, Amita Aggarwal, et al.
Rheumatology International|April 12, 2018
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Alessandro Consolaro, Francesca Bovis, Angela Pistorio, et al.
Arthritis and Rheumatism|January 1, 2008
The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation studyNicolino Ruperto, Angelo Ravelli, Angela Pistorio, et al.
Rheumatology International|May 23, 2018
Correction to: The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Alessandro Consolaro, Francesca Bovis, Angela Pistorio, et al.
Clinical and Experimental Rheumatology|February 25, 2011
Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositisDinara Guseinova, Alessandro Consolaro, Lucia Trail, et al.
Pageof 35

Showing results (281-290 of 342) with videos related to

Sort By:
Pageof 35
Rheumatology (Oxford, England)|July 26, 2024
Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR projectFrancesco Baldo, Remco G A Erkens, Mao Mizuta, et al.
Rheumatology (Oxford, England)|August 30, 2023
Early anakinra treatment improves cardiac outcome of multisystem inflammatory syndrome in children, regardless of disease severityAndrea Taddio, Sara Della Paolera, Luisa Abbagnato, et al.
Lancet (London, England)|February 7, 2017
Intra-articular corticosteroids versus intra-articular corticosteroids plus methotrexate in oligoarticular juvenile idiopathic arthritis: a multicentre, prospective, randomised, open-label trialAngelo Ravelli, Sergio Davì, Giulia Bracciolini, et al.
JAMA|April 8, 2010
Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trialDirk Foell, Nico Wulffraat, Lucy R Wedderburn, et al.
Rheumatology (Oxford, England)|August 3, 2021
Canakinumab in systemic juvenile idiopathic arthritis: real-world data from a retrospective Italian cohortArianna De Matteis, Claudia Bracaglia, Denise Pires Marafon, et al.
Arthritis Care & Research|December 25, 2024
Do the Provisional Paediatric Rheumatology International Trials Organisation Enthesitis/Spondylitis-Related Juvenile Idiopathic Arthritis Criteria Capture Youth With Axial Spondyloarthritis?Pamela F Weiss, Timothy G Brandon, Amita Aggarwal, et al.
Rheumatology International|April 12, 2018
The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Alessandro Consolaro, Francesca Bovis, Angela Pistorio, et al.
Arthritis and Rheumatism|January 1, 2008
The provisional Paediatric Rheumatology International Trials Organisation/American College of Rheumatology/European League Against Rheumatism Disease activity core set for the evaluation of response to therapy in juvenile dermatomyositis: a prospective validation studyNicolino Ruperto, Angelo Ravelli, Angela Pistorio, et al.
Rheumatology International|May 23, 2018
Correction to: The Italian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Alessandro Consolaro, Francesca Bovis, Angela Pistorio, et al.
Clinical and Experimental Rheumatology|February 25, 2011
Comparison of clinical features and drug therapies among European and Latin American patients with juvenile dermatomyositisDinara Guseinova, Alessandro Consolaro, Lucia Trail, et al.
Pageof 35